{"id":481,"date":"2019-01-08T16:38:13","date_gmt":"2019-01-08T15:38:13","guid":{"rendered":"https:\/\/triton.u707.jussieu.fr\/hepatherWP_test\/?p=481"},"modified":"2022-04-27T15:04:39","modified_gmt":"2022-04-27T13:04:39","slug":"actu-d","status":"publish","type":"post","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/","title":{"rendered":"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C."},"content":{"rendered":"<p>Une analyse r\u00e9alis\u00e9e chez pr\u00e8s de 10,000 patients de la cohorte, documente les b\u00e9n\u00e9fices cliniques \u00e0 court terme des antiviraux \u00e0 action directe dans le traitement de l\u2019infection par le virus de l\u2019h\u00e9patite C. Avec un suivi de 33 mois en m\u00e9diane, l\u2019analyse a montr\u00e9 que le traitement de l\u2019h\u00e9patite C avec les antiviraux \u00e0 action directe \u00e9tait associ\u00e9 \u00e0 une diminution de la mortalit\u00e9 et de la survenue de carcinome h\u00e9patocellulaire (cancer du foie).<br \/>\nCes r\u00e9sultats font l\u2019objet d\u2019une publication dans The Lancet ce 11 f\u00e9vrier 2018 (<strong><a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(18)32111-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(18)32111-1\/fulltext<\/a><\/strong>).<br \/>\nVoir le communiqu\u00e9 de presse de l\u2019INSERM-ANRS : <a href=\"https:\/\/www.anrs.fr\/fr\/presse\/communiques-de-presse\/573\/aad-confirmation-de-lefficacite-clinique-court-terme-en-vie-reelle\" target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/www.anrs.fr\/fr\/actualites\/574\/aad-confirmation-de-lefficacite-clinique-court-terme-en-vie-reelle<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Une analyse r\u00e9alis\u00e9e chez pr\u00e8s de 10,000 patients de la cohorte, documente les b\u00e9n\u00e9fices cliniques \u00e0 court terme des antiviraux \u00e0 action directe dans le traitement de l\u2019infection par le virus de l\u2019h\u00e9patite C. Avec un suivi de 33 mois en m\u00e9diane, l\u2019analyse a montr\u00e9 que le traitement de l\u2019h\u00e9patite C avec les antiviraux \u00e0 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[2],"tags":[],"class_list":["post-481","post","type-post","status-publish","format-standard","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C. - ANRS CO22 HEPATHER<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C. - ANRS CO22 HEPATHER\" \/>\n<meta property=\"og:description\" content=\"Une analyse r\u00e9alis\u00e9e chez pr\u00e8s de 10,000 patients de la cohorte, documente les b\u00e9n\u00e9fices cliniques \u00e0 court terme des antiviraux \u00e0 action directe dans le traitement de l\u2019infection par le virus de l\u2019h\u00e9patite C. Avec un suivi de 33 mois en m\u00e9diane, l\u2019analyse a montr\u00e9 que le traitement de l\u2019h\u00e9patite C avec les antiviraux \u00e0 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/\" \/>\n<meta property=\"og:site_name\" content=\"ANRS CO22 HEPATHER\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-08T15:38:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-27T13:04:39+00:00\" \/>\n<meta name=\"author\" content=\"admin_ft\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_ft\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/\"},\"author\":{\"name\":\"admin_ft\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/person\/66fbad7501a64c79dc989c2c4b672502\"},\"headline\":\"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C.\",\"datePublished\":\"2019-01-08T15:38:13+00:00\",\"dateModified\":\"2022-04-27T13:04:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/\"},\"wordCount\":149,\"publisher\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/\",\"name\":\"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C. - ANRS CO22 HEPATHER\",\"isPartOf\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website\"},\"datePublished\":\"2019-01-08T15:38:13+00:00\",\"dateModified\":\"2022-04-27T13:04:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\",\"name\":\"ANRS CO22 HEPATHER\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization\",\"name\":\"IPLESP UMRS 1136\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1\",\"width\":464,\"height\":175,\"caption\":\"IPLESP UMRS 1136\"},\"image\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/person\/66fbad7501a64c79dc989c2c4b672502\",\"name\":\"admin_ft\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/32aec5431cbe09c4fa8b01afcd47f8c21f1b273c5fdfeda86a83dc2bb7241767?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/32aec5431cbe09c4fa8b01afcd47f8c21f1b273c5fdfeda86a83dc2bb7241767?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/32aec5431cbe09c4fa8b01afcd47f8c21f1b273c5fdfeda86a83dc2bb7241767?s=96&d=mm&r=g\",\"caption\":\"admin_ft\"},\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/author\/admin_ft\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C. - ANRS CO22 HEPATHER","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/","og_locale":"fr_FR","og_type":"article","og_title":"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C. - ANRS CO22 HEPATHER","og_description":"Une analyse r\u00e9alis\u00e9e chez pr\u00e8s de 10,000 patients de la cohorte, documente les b\u00e9n\u00e9fices cliniques \u00e0 court terme des antiviraux \u00e0 action directe dans le traitement de l\u2019infection par le virus de l\u2019h\u00e9patite C. Avec un suivi de 33 mois en m\u00e9diane, l\u2019analyse a montr\u00e9 que le traitement de l\u2019h\u00e9patite C avec les antiviraux \u00e0 [&hellip;]","og_url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/","og_site_name":"ANRS CO22 HEPATHER","article_published_time":"2019-01-08T15:38:13+00:00","article_modified_time":"2022-04-27T13:04:39+00:00","author":"admin_ft","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin_ft","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/#article","isPartOf":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/"},"author":{"name":"admin_ft","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/person\/66fbad7501a64c79dc989c2c4b672502"},"headline":"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C.","datePublished":"2019-01-08T15:38:13+00:00","dateModified":"2022-04-27T13:04:39+00:00","mainEntityOfPage":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/"},"wordCount":149,"publisher":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization"},"articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/","name":"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C. - ANRS CO22 HEPATHER","isPartOf":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website"},"datePublished":"2019-01-08T15:38:13+00:00","dateModified":"2022-04-27T13:04:39+00:00","breadcrumb":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-d\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/"},{"@type":"ListItem","position":2,"name":"HEPATHER, premi\u00e8re \u00e9tude de grande ampleur en vie r\u00e9elle qui montre l\u2019efficacit\u00e9 clinique \u00e0 court terme des antiviraux directs dans l\u2019h\u00e9patite C."}]},{"@type":"WebSite","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/","name":"ANRS CO22 HEPATHER","description":"","publisher":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization","name":"IPLESP UMRS 1136","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1","contentUrl":"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1","width":464,"height":175,"caption":"IPLESP UMRS 1136"},"image":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/person\/66fbad7501a64c79dc989c2c4b672502","name":"admin_ft","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/32aec5431cbe09c4fa8b01afcd47f8c21f1b273c5fdfeda86a83dc2bb7241767?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/32aec5431cbe09c4fa8b01afcd47f8c21f1b273c5fdfeda86a83dc2bb7241767?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32aec5431cbe09c4fa8b01afcd47f8c21f1b273c5fdfeda86a83dc2bb7241767?s=96&d=mm&r=g","caption":"admin_ft"},"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/author\/admin_ft\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":false,"jetpack_shortlink":"https:\/\/wp.me\/paQKc4-7L","jetpack-related-posts":[{"id":3290,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/4-travaux-publies-en-2019-dans-le-domaine-de-lhepatite-virale-c\/","url_meta":{"origin":481,"position":0},"title":"4 travaux publi\u00e9s en 2019 dans le domaine de l\u2019h\u00e9patite virale C","author":"admin_fchau","date":"3 novembre 2019","format":false,"excerpt":"4 travaux publi\u00e9s en 2019 dans le domaine de l\u2019h\u00e9patite virale C \u00a0 A notre connaissance, l'\u00e9tude de cohorte ANRS CO22 Hepather a \u00e9t\u00e9 la premi\u00e8re \u00e9tude longitudinale prospective \u00e0 explorer les r\u00e9sultats cliniques associ\u00e9s au traitement par anti-viraux directs (AVD) chez les patients atteints d'h\u00e9patite C chronique, en comparant\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":475,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-a\/","url_meta":{"origin":481,"position":1},"title":"HEPATHER, source de donn\u00e9es pour une \u00e9tude command\u00e9e par la Haute Autorit\u00e9 de Sant\u00e9 concernant l\u2019efficacit\u00e9 virologique et la s\u00e9curit\u00e9 des antiviraux \u00e0 action directe dans le traitement de l\u2019h\u00e9patite C chronique chez les patients avec fibrose h\u00e9patique absente \u00e0 mod\u00e9r\u00e9e (F0\/F1)","author":"admin_ft","date":"8 janvier 2019","format":false,"excerpt":"Le 25 mai 2016, Marisol Touraine alors ministre des affaires sociales et de la sant\u00e9 annon\u00e7ait le traitement \u00ab\u00a0universel\u00a0\u00bb de l\u2019h\u00e9patite chronique C en France avec des antiviraux directs. La Haute Autorit\u00e9 de Sant\u00e9, en charge notamment de l\u2019\u00e9valuation des produits de sant\u00e9, a sollicit\u00e9 une \u00e9valuation de l\u2019efficacit\u00e9 et\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":479,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/actu-c\/","url_meta":{"origin":481,"position":2},"title":"Pas de diff\u00e9rence dans la vitesse de progression de la r\u00e9cidive de carcinome h\u00e9patocellulaire en lien avec le traitement par antiviraux directs.","author":"admin_ft","date":"8 janvier 2019","format":false,"excerpt":"Il est aujourd\u2019hui admis que le traitement de l\u2019h\u00e9patite C par antiviraux directs n\u2019augmente pas le risque de r\u00e9cidive de carcinome h\u00e9patocellulaire chez les patients ayant re\u00e7u un traitement curatif pour ce cancer. La question demeurait n\u00e9anmoins d\u2019une progression plus rapide de cette r\u00e9cidive lorsqu\u2019elle survient chez les patients recevant\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3303,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/deja-11-travaux-publies-en-2021\/","url_meta":{"origin":481,"position":3},"title":"D\u00e9j\u00e0 11 travaux publi\u00e9s en 2021\u00a0!","author":"admin_fchau","date":"23 novembre 2021","format":false,"excerpt":"D\u00e9j\u00e0 11 travaux publi\u00e9s en 2021\u00a0! H\u00e9patite virale C\u00a0: Au cours des 4 derni\u00e8res ann\u00e9es, plusieurs \u00e9tudes ont port\u00e9 sur l'identification ou la pr\u00e9diction du carcinome h\u00e9patocellulaire chez les patients infect\u00e9s par l'h\u00e9patite C, avant ou apr\u00e8s la gu\u00e9rison virologique. La biobanque de cohorte a, entre autre, \u00e9t\u00e9 utilis\u00e9e pour\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3393,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/2024-une-annee-de-preparation-et-de-transition-3-publications-par-lequipe-du-sesstim\/","url_meta":{"origin":481,"position":4},"title":"2024 &#8211; une ann\u00e9e de pr\u00e9paration et de transition. 3 publications par l&rsquo;\u00e9quipe du SESSTIM.","author":"admin_fchau","date":"17 mars 2025","format":false,"excerpt":"L'ann\u00e9e 2024 a \u00e9t\u00e9 marqu\u00e9e par la pr\u00e9paration de la suite de la cohorte HEPATHER dont la date de fin \u00e9tait programm\u00e9e au 31 d\u00e9cembre 2024.Hepat-B proposera de prolonger le suivi des patients atteints d'h\u00e9patite B inclus dans Hepather jusqu'en 2029, avec la r\u00e9alisation de nouvelles collections biologiques. Cette cohorte\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3376,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/2023-premiers-travaux-issus-du-chainage-individuel-des-donnees-de-la-cohorte-hepather-avec-le-systeme-national-des-donnees-de-sante-5-publications\/","url_meta":{"origin":481,"position":5},"title":"2023 &#8211; Premiers travaux issus du cha\u00eenage individuel des donn\u00e9es de la cohorte Hepather avec le Syst\u00e8me National des Donn\u00e9es de Sant\u00e9. 5 publications","author":"admin_fchau","date":"17 d\u00e9cembre 2024","format":false,"excerpt":"Le cha\u00eenage avec les donn\u00e9es du Syst\u00e8me National des Donn\u00e9es de Sant\u00e9 (SDNS) autoris\u00e9 par la commission nationale informatique et libert\u00e9 en 2018 a \u00e9t\u00e9 r\u00e9alis\u00e9 pour plus de 80% des participants de la cohorte qui ont donn\u00e9 leur consentement, \u00e0 partir de la reconstruction du num\u00e9ro d'identification au r\u00e9pertoire\u2026","rel":"","context":"Dans &quot;Actualit\u00e9s&quot;","block_context":{"text":"Actualit\u00e9s","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/category\/actualites\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/posts\/481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/comments?post=481"}],"version-history":[{"count":5,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/posts\/481\/revisions"}],"predecessor-version":[{"id":3325,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/posts\/481\/revisions\/3325"}],"wp:attachment":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/media?parent=481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/categories?post=481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/tags?post=481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}